New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
09:16 EDTNVTL, VMEM, ALSK, FEYE, NLNK, GTAT, FRM, SWY, BIG, DLIA, SKUL, FLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Foot Locker (FL), up 5.5%... Skullcandy (SKUL), up 25%... Big Lots (BIG), up 16%... Alaska Communications (ALSK), up 11%...ALSO HIGHER: dELiA's (DLIA), up 11% after Tiger Global Management reports 6.3% passive stake in the company... GT Advanced (GTAT), up 7% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Furmanite (FRM), down 3.8%... Novatel Wireless (NVTL), down 23%... Peregrine Pharmaceuticals (PPHM), down 10%. ALSO LOWER: NewLink (NLNK), down 9.7% after saying will continue IMPRESS Phase 3 study of algenpantucel-L... Violin Memory (VMEM), down 12.4% after earnings, downgrade at BofA/Merrill... FireEye (FEYE), down 6.6% after 14M share secondary offering of stock priced at $82.00... Safeway (SWY), down 3% after announcing a deal to be acquired by Albertsons for about an estimated $40 per share in a merger that had been reported on extensively.
News For FL;SKUL;DLIA;BIG;SWY;FRM;GTAT;NLNK;FEYE;ALSK;VMEM;NVTL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 17, 2014
06:14 EDTFLFoot Locker pullback a buying opportunity, says Citigroup
Subscribe for More Information
October 16, 2014
10:01 EDTFEYEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
05:31 EDTFEYEFireEye upgraded to Overweight from Neutral at JPMorgan
Subscribe for More Information
October 15, 2014
10:49 EDTNLNKEbola linked names rise again amid broader market sell-off
Subscribe for More Information
06:37 EDTGTATGT Advanced executive sold shares before bankruptcy, WSJ says
Subscribe for More Information
06:16 EDTGTATApple asks permission to lodge objections to GT bankrupcy in secret, Re/code says
Subscribe for More Information
October 14, 2014
15:01 EDTNLNKNewLink Genetics December volatility elevated at 181 on wide price movement
NewLink Genetics October call option implied volatility of 123, November is at 130, December is at 181; compared to its 26-week average of 104 according to Track Data, suggesting large price movement for this company identified as developing potential Ebola treatments.
11:19 EDTNLNKNIH says several potential Ebola treatments under development
Subscribe for More Information
10:10 EDTNLNKNIH director says supporting BioCryst, Chimerix Ebola treatments
Subscribe for More Information
09:04 EDTNLNKChinese company says drug can cure Ebola, Reuters reports
Subscribe for More Information
October 13, 2014
16:04 EDTSKULSkullcandy announces two ASTRO headsets compatible with Xbox One
Subscribe for More Information
11:15 EDTNLNKEbola vaccine licensed to NewLink begins human trials
Canada's Minister of Health announced the launch of Phase 1 clinical trials for Canada's Ebola vaccine, which was developed by scientists at the Public Health Agency of Canada's National Microbiology Laboratory. The Canadian government owns the intellectual property associated with this vaccine and has licensed the rights to NewLink Genetics through its wholly owned subsidiary BioProtection Systems. The Phase 1 clinical trial will test the vaccine on a small group of people to assess its safety, determine the appropriate dosage and identify any side effects.
10:26 EDTSKULSkullcandy management to meet with Roth Capital
Subscribe for More Information
09:39 EDTGTATActive equity options trading on open
Subscribe for More Information
09:23 EDTFEYEHP could buy lower valuation company, says Bernstein
Subscribe for More Information
October 12, 2014
19:26 EDTNLNKPatient being evaluated at Boston hospital for possible Ebola, Boston Globe says
Health officials say that a man that recently traveled to Liberia is being assessed at Beth Israel Deaconess hospital in Boston for the Ebola virus, the Boston Globe says. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
19:12 EDTNLNKCDC confirms Texas healthcare worker positive for Ebola
Subscribe for More Information
17:34 EDTFEYEJPMorgan to double spending on cybersecurity over next five years, WSJ says
Subscribe for More Information
14:18 EDTNLNKNY's JFK Airport begins Ebola screenings, WSJ says
Subscribe for More Information
12:48 EDTNLNKTexas health-care worker tests positive for Ebola, WSJ says
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use